Soru

Zorluk: Çok zorInfectious Disease Mechanisms

During a didactic session on the pharmacology of chronic viral hepatitis, an infectious disease specialist highlights the unique replication mechanism of a specific hepatotropic virus. The physician emphasizes that unlike standard DNA viruses, this pathogen's eradication is exceptionally difficult due to a stable nuclear episome, and its targeted pharmacotherapy actually relies on inhibiting a viral reverse transcriptase. The discussion focuses on the precise molecular events that occur immediately after the virus binds to the host sodium taurocholate cotransporting polypeptide (NTCP) receptor and uncoats in the cytoplasm.

Arrange the following molecular events in the correct chronological sequence of this pathogen's intracellular replication cycle, beginning immediately after viral uncoating.

  1. 1Transport of the partially double-stranded relaxed circular DNA (rcDNA) into the host nucleus
  2. 2Host-enzyme mediated repair of the viral genome to form covalently closed circular DNA (cccDNA)
  3. 3Transcription of the viral episome by host RNA polymerase II to generate pregenomic RNA (pgRNA)
  4. 4Encapsidation of the RNA intermediate along with the viral polymerase into a new core particle
  5. 5Synthesis of new negative-strand DNA via reverse transcription within the cytoplasmic capsid
  6. 6Maturation via partial positive-strand DNA synthesis and envelopment at the endoplasmic reticulum

Cevap

The correct sequence of Hepatitis B Virus replication begins with rcDNA entering the nucleus, conversion to cccDNA, transcription into pgRNA, cytoplasmic encapsidation of pgRNA, reverse transcription inside the new capsid, and final envelopment.
Hepatitis B Virus (HBV) has a highly unique replication cycle for a DNA virus. Upon cellular entry via the NTCP receptor, the nucleocapsid delivers its relaxed circular DNA (rcDNA) into the host nucleus. Host DNA repair machinery converts rcDNA into covalently closed circular DNA (cccDNA), which forms a stable episome responsible for chronic infection. Host RNA polymerase II transcribes this cccDNA to generate pregenomic RNA (pgRNA) and subgenomic mRNAs. The pgRNA is exported to the cytoplasm where it is encapsidated along with the viral polymerase. Unlike retroviruses, HBV's reverse transcription occurs inside this newly formed cytoplasmic core particle, converting the pgRNA back into a DNA genome. Finally, the mature nucleocapsid buds through the endoplasmic reticulum to acquire its envelope and exit the cell.

Adım Adım Çözüm

1
Identify the specific pathogen based on the pharmacological and molecular clues in the stem.
The pathogen is Hepatitis B Virus (HBV), identified by NTCP receptor binding, the presence of a nuclear episome, and reliance on a reverse transcriptase despite being a DNA virus.
Understanding the pathogen is required to accurately map its unique life cycle.
2
Determine the initial intracellular events following uncoating.
The partially double-stranded relaxed circular DNA (rcDNA) is transported to the nucleus and repaired by host enzymes into covalently closed circular DNA (cccDNA).
HBV must establish a stable nuclear template before it can produce viral proteins or replicate its genome.
3
Sequence the production of the viral intermediate.
The cccDNA is transcribed by host RNA polymerase II into pregenomic RNA (pgRNA) which exits the nucleus.
Because HBV is a pararetrovirus, it replicates its DNA genome through an RNA intermediate.
4
Sequence the final cytoplasmic assembly and genome synthesis steps.
The pgRNA is encapsidated, followed by reverse transcription into negative-strand DNA within the capsid, and finally, envelopment at the endoplasmic reticulum.
Reverse transcription must occur physically inside the newly formed capsid to protect the viral genome before it acquires its envelope for cellular export.

Anahtar Kavram

Hepatitis B Virus (HBV) intracellular replication cycle and the molecular basis of chronicity (cccDNA)
Bu soruyu puanla